These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30808975)

  • 1. MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer.
    Wang Y; Li X; Liu W; Li B; Chen D; Hu F; Wang L; Liu XM; Cui R; Liu R
    Oncogene; 2019 Jun; 38(24):4820-4834. PubMed ID: 30808975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.
    Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Int J Urol; 2019 Apr; 26(4):506-520. PubMed ID: 30818424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity.
    Wang Y; Shao N; Mao X; Zhu M; Fan W; Shen Z; Xiao R; Wang C; Bao W; Xu X; Yang C; Dong J; Yu D; Wu Y; Zhu C; Wen L; Lu X; Lu YJ; Feng N
    Oncotarget; 2016 Jul; 7(30):47444-47464. PubMed ID: 27329728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1.
    Lu K; Liu C; Tao T; Zhang X; Zhang L; Sun C; Wang Y; Chen S; Xu B; Chen M
    FEBS Lett; 2015 Jun; 589(13):1485-90. PubMed ID: 25936765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.
    Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N
    Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
    Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST
    Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
    Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
    Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of miR-582-5p regulates cellular proliferation of prostate cancer cells under androgen-deprived conditions.
    Maeno A; Terada N; Uegaki M; Goto T; Okada Y; Kobayashi T; Kamba T; Ogawa O; Inoue T
    Prostate; 2014 Dec; 74(16):1604-12. PubMed ID: 25176332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.
    Scaravilli M; Porkka KP; Brofeldt A; Annala M; Tammela TL; Jenster GW; Nykter M; Visakorpi T
    Prostate; 2015 Jun; 75(8):798-805. PubMed ID: 25731699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1.
    Zhang X; Tao T; Liu C; Guan H; Huang Y; Xu B; Chen M
    Oncol Rep; 2016 Jul; 36(1):376-82. PubMed ID: 27175617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
    Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
    Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
    Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
    Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA-3622 family at the 8p21 locus exerts oncogenic effects by regulating the p53-downstream gene network in prostate cancer progression.
    Zhang Y; Xu Z; Wen W; Liu Z; Zhang C; Li M; Hu F; Wei S; Bae S; Zhou J; Liu R; Wang L
    Oncogene; 2022 Jun; 41(23):3186-3196. PubMed ID: 35501464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer.
    Fu W; Hong Z; You X; Din J; Chen B; Zhao B; Yuan G; Li Q
    Biomed Pharmacother; 2019 Oct; 118():109374. PubMed ID: 31545228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional roles of miR-625-5p and miR-874-3p in the progression of castration resistant prostate cancer.
    Aktan Ç; Çal Ç; Kaymaz B; Selvi Günel N; Kıpçak S; Özel B; Gündüz C; Şahin Küçükaslan A; Aygüneş Jafari D; Kosova B
    Life Sci; 2022 Jul; 301():120603. PubMed ID: 35508255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.
    Ishteiwy RA; Ward TM; Dykxhoorn DM; Burnstein KL
    PLoS One; 2012; 7(12):e52106. PubMed ID: 23300597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
    Goto Y; Kojima S; Nishikawa R; Kurozumi A; Kato M; Enokida H; Matsushita R; Yamazaki K; Ishida Y; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Br J Cancer; 2015 Sep; 113(7):1055-65. PubMed ID: 26325107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55.
    You B; Zhang KC
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7660-7670. PubMed ID: 30536308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.
    Saini S; Majid S; Shahryari V; Tabatabai ZL; Arora S; Yamamura S; Tanaka Y; Dahiya R; Deng G
    Mol Cancer Ther; 2014 Jul; 13(7):1952-63. PubMed ID: 24817628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
    Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.